Navigation Links
Genetics determine optimal drug dose of common anticoagulant
Date:8/21/2007

(WASHINGTON, August 21, 2007) Genetic testing can be used to help personalize the therapeutic dosage of warfarin, a commonly-used anticoagulant, according to research published in the September 1, 2007, issue of Blood, the journal of the American Society of Hematology. This result represents one of the first applications of using an individuals genetic information to guide personal medical care.

Because individuals metabolize drugs differently, varying doses of warfarin are needed for the drug to be effective in each patient. Too much warfarin can cause severe bleeding, and too little can cause dangerous blood clots. Currently, there is little guidance for predicting how much of the drug a person will need. Physicians have had to roughly estimate an initial dose of warfarin and then continually monitor a patients International Normalized Ratio (INR) value (a measure of how fast the blood clots), during treatment to tweak the dosage by trial and error.

For the first time, a group of St. Louis researchers combined the standard INR method with genetic testing to predict the therapeutic warfarin dose. Since warfarin is often prescribed after major orthopedic surgery to prevent blood clots in the legs, the study followed 92 adults undergoing either total hip or knee replacement at the Washington University Medical Center, who had never previously taken the anticoagulant.

Prior to warfarin treatment, the researchers collected blood samples and each patients medical history. The blood tests were used to examine variations in two genes, CYP2C9 and VKORC1, that may affect warfarin dosing. Variants in CYP2C9 impair the bodys breakdown of warfarin; variants in VKORC1 cause increased warfarin sensitivity. The patients were assigned initial doses of warfarin based on clinical factors and their genotype. The researchers followed the patients until successful treatment outcomes were achieved several weeks later.

By combining varia
'/>"/>

Contact: Laura Stark
lstark@hematology.org
202-552-4914
American Society of Hematology
Source:Eurekalert

Page: 1 2

Related biology news :

1. Mosaic mouse technique offers a powerful new tool to study diseases and genetics
2. Genetics links whale to two different ocean basins
3. New technique could alter field of mouse genetics
4. Scientists unpick genetics of first 15 minutes of life
5. New research examines genetics of successful aging
6. Alcoholism, smoking and genetics among Plains American Indians
7. New research examines genetics of successful aging
8. Newly-discovered class of genes determines ?and restricts ?stem cell fate
9. Biologists determine genetic blueprint of social amoeba
10. International Team Determines Geographic Origin of Leprosy
11. USC researchers determine mechanism of action of chemotherapy drug

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2009)...ildren exposed prenatally to tobacco smoke and dur...k for ADHD, according to research done at Cincinna...dy estimates that up to 35 percent of ADHD cases i...educed by eliminating both of these environmental ... children , "Tobacco and lead exposure each hav...
(Date:11/22/2009)...ited gene deletion can increase the likelihood of ...antation, an international team of researchers rep...ature Genetics . When the gene, called UGT2B17, is...e recipient,s, transplants have a significantly gr...-versus-host disease, in which immune cells from t...
(Date:11/22/2009)...e Brain Research Centre, a partnership of the Univ... Vancouver Coastal Health Research Institute, have...which brain cells die following a stroke, as well ...ults of the study were recently published online i...brain cells continue to die even after blood flow ...
Breaking Biology News(10 mins):Exposure to lead, tobacco smoke raises risk of ADHD 2Gene mismatch influences success of bone marrow transplants 2Gene mismatch influences success of bone marrow transplants 3Gene mismatch influences success of bone marrow transplants 4New understanding about mechanism for cell death after stroke leads to possible therapy 2Caraco Pharmaceutical Laboratories Ltd Closes Asset Purchase Agreement with Forest Laboratories Inc to Settle Lexapro 28R 29 28escitalopram oxala 5189 1Caraco Pharmaceutical Laboratories Ltd Closes Asset Purchase Agreement with Forest Laboratories Inc to Settle Lexapro 28R 29 28escitalopram oxala 5189 2Survey finds just 40 percent of adults absolutely certain they will get H1N1 vaccine 58762 1Survey finds just 40 percent of adults absolutely certain they will get H1N1 vaccine 58762 2Survey finds just 40 percent of adults absolutely certain they will get H1N1 vaccine 58762 3Survey finds just 40 percent of adults absolutely certain they will get H1N1 vaccine 58762 4Cholesterol necessary for brain development 10237 1
...ard H. Ebright and his collaborators have resolved...ental life process that was the subject of the 200...e first step in the process cells employ to read a...es. Transcription is carried out by a molecular ma...n RNA copy of the information in DNA. , Two pa...
...esearchers have developed two new technologies for...rst patent-pending technology provides a way for r...aboratory are responding to an anti-cancer drug. T...s at once -- allows for the simultaneous testing o...g on different kinds of cells taken from the body....
...s at Chicago study has been stopped early due to p...ision of men reduces their risk of acquiring HIV d...e study,s independent Data Safety and Monitoring B... on the board,s review, the National Institutes of...men enrolled in the study who remain uncircumcised...
Other Biology News:Nanotech tools yield DNA transcription breakthrough 2Nanotech tools yield DNA transcription breakthrough 3Nanotech tools yield DNA transcription breakthrough 4Chemical tests of cell growth enter third dimension 2Chemical tests of cell growth enter third dimension 3Male circumcision reduces HIV risk, study stopped early 2Male circumcision reduces HIV risk, study stopped early 3
(Date:11/23/2009)...ch.,Nov.23/PRNewswire-FirstCall/--NeogenCorporatio...,Ph.D.,waselectedtoNeogen,sBoardofDirectorsattheco...owderhasmorethan40yearsofexperienceinthefood,agric...unctprofessorofagriculturaleconomicsatVirginiaTech...nitedStateschiefagriculturenegotiatorwiththerankof...
(Date:11/23/2009)...,Nov.23/PRNewswire/-InimexPharmaceuticals,Inc.anno...itsPresidentandCEO. ,, Abramsbringsmorethan25ye....Heisaco-inventorofthenuclearmedicineimagingagent,...,plcwherehewasManager,BiomedicalResearchWorldwide....,BCandwasPresidentandCEOfrom1996to2006.AnorMEDdisc...
(Date:11/23/2009)...Nov.23/PRNewswire-FirstCall/--CornerstoneTherapeut...panyfocusedonacquiring,developingandcommercializin...elatedmarkets,todayannouncedthatCraigA.Collard,Pre...rporateoverviewatthe21stAnnualPiperJaffrayHealthCa...TheNewYorkPalaceHotelinNewYorkCity. ,, Aliveaud...
(Date:11/20/2009)...GO, Nov. 20 Veridiam (www.veridiam...-size company category at the 2009 Workplace Excel...Diego Society for Human Resources Management and r...s practices. ,, Veridiam was one of nine winner...companies, honored at the recent awards ceremony. ...
Breaking Biology Technology:Richard T. Crowder Joins Neogen's Board of Directors 2Inimex Announces Appointment of New CEO 2Cornerstone Therapeutics to Present at the 21st Annual Piper Jaffray Health Care Conference 2Veridiam Wins Workplace Excellence Crystal Award in Mid-Size Company Category 2
...GA, ON, Oct. 11 /PRNewswire-FirstCall/ - YM BioSci...logy company that identifies, develops,and commerc...wide, today,advised that its Annual Meeting of Sha...t 4:00pm at the Gallery of the TSX Broadcast & Con...t West, Toronto, Ontario. The items for considera...
... Oppose Proposal to Kill Human Embryos for Researc...ference President and Chief Executive Officer Sist...atement today regarding the formation of the,ballo...In order to protect human life at its most vulnera...ated, that seeks to clone and/or kill,human embryo...
...zerland, October 11 The young Swiss biotech,enter... Michel Klein, one,of the world,s most renowned va...ice President of Science & Technology of the Avent...ship of the scientific sector of,vaccine developme...as,access to an outstanding network across one of ...
Other Biology Technology:YM BIOSCIENCES NOTICE OF ANNUAL MEETING OF SHAREHOLDERS AND NOMINATION OF DIRECTORS 2YM BIOSCIENCES NOTICE OF ANNUAL MEETING OF SHAREHOLDERS AND NOMINATION OF DIRECTORS 3Prof. Michel Klein Becomes Chief Scientific Officer at AMVAC 2
...t not structural information the AXIMA-LNR linear ...high throughput QA/QC applications and for high pe...lude oligonucleotide QA/QC, SNP analysis, protein ...d polymer analysis, with the ability to run up to ...
RAOEC (R304-05) from European Collection of Cell Cultures (ECACC)
...modular instrument which can be used for a variety...lar, Transducer & Multi-channel Isolated Amplifica...L900D) forms the heart of every NeuroLog System. ...ing within the case allows signals to be passed be...
Mouse Anti-Drosophila Yan Drosophila protein Antibody, Unconjugated from Developmental Studies Hybridoma Bank
Biology Products: